César has a Ph.D. in Green Chemistry and Catalysis from the University of St Andrews and R&D experience in multiple research universities around the globe. He co-leads business development.
Mark obtained his Ph.D. from Manchester University, 1986-1989, under the tutelage of the renowned Organometallic Chemist Professor Brian Booth. From there he joined Merck Process Research group in the...
Alfred Y. Lee is a Senior Principal Scientist in the Department of Analytical Research & Development at Merck & Co., Inc. (USA). Prior to his current position, Dr. Lee...
By Dr. Samir Kulkarni, Ph.D. Pfizer, Groton, CT The improved development and scaleup of Nirmatrelvir (the active 3CL protease inhibitor in PaxlovidTM) with efficient chemical synthesis led to FDA...
Dr. Samir Kulkarni is currently working as Senior Principal Scientist in Pharmaceutical Sciences, Pfizer Chemical R＆D working in Groton, CT. He earned his Ph.D. in Chemical Engineering at Delft...
By Dr. Ashish Punia, Ph.D. Merck & Co., Rahway, NJ A considerable portion of small molecule pharmaceutical drugs suffer from poor aqueous solubility. Amorphous solid dispersion (ASD) is a...
Ashish Punia is a Principal Scientist in the Materials and Biophysical Characterization Group at Merck & Co., Inc., Rahway NJ. Prior to joining Merck, he received his PhD in...
By Prof. Rajesh N. Davé, Distinguished Professor, Chemical & Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102 Distinguished Professor of Chemical, Biological and Pharmaceutical Engineering, Center for...
Prof. Rajesh Davé Fellow of the American Institute of Chemical Engineers (AIChE), American Association of Pharmaceutical Scientists (AAPS), and National Academy of Inventors (NAI) is a Distinguished Professor of...
VP, head of CMC, Supply Chain and QA Chong-Hui Gu, Ph. D, is responsible for CMC, supply chain and QA at Foghorn Therapeutics. He has over 20 years of...
